Contact: Karen Kreeger
University of Pennsylvania School of Medicine
Caption: This is a model of a stabilized, alpha-helical inhibitor of the human protease calpain. The blue inhibitor is shown as model of how it is predicted to fit into the protease active site (yellow).
Credit: Nataline Meinhardt and Doron C. Greenbaum, Perelman School of Medicine, University of Pennsylvania
Usage Restrictions: None
Related news release: Penn team developing new class of malaria drugs using essential calcium enzyme